Jiwei Guo

11PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMolecular targetsNgā pūnaha whakahaere mōhiohio me te mātauranga o te Māori (Māori information and knowledge management systems)Medical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 02, 2020
Corrigendum to "UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells".

Yan Wu, Dan Jin, Xiaohong Wang

|Feb 29, 2020
m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.

Dan Jin, Jiwei Guo, Yan Wu

|Jan 08, 2020
Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.

Dan Jin, Jiwei Guo, Yan Wu

|Dec 11, 2019
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.

Dan Jin, Jiwei Guo, Yan Wu

|Jul 09, 2019
Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway.

Xiaohong Wang, Yong Han, Jian Liu

|Jan 30, 2019
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells.

Yan Wu, Dan Jin, Xiaohong Wang

Pageof 2

Frequent Collaborators

2 joint publications

Xiaohong Wang

1 joint publications

Zhenlin Yang